University of Sao Paulo

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

263

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

4 drugs in development

Phase 31

Phase 22

Phase 11

Preclinical1

By Therapeutic Area

top 3

Psychiatry

120%

Oncology

120%

Neurology

120%

R&D Momentum

79/100

Pipeline Velocity

59/100

Trial Completion Rate

91/100

Pipeline Concentration

28/100

Pipeline Freshness

26/100

Strategic Signals

↗Early-stage heavy pipeline may seek late-stage partners
↗Active in Psychiatry but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Nov 3, 2026

Completed

Single-dose Effects of Ayahuasca Compared to Esketamine on Experimentally Induced Pain: a Randomized, Double-blind Study

Oct 27, 2026

Enrolling by invitation

Acute Effects of a Single Dose of Ayahuasca on Cerebral Metabolism in Healthy Volunteers: a PET Study

Oct 27, 2026

Completed

Effects of Different Doses of Ayahuasca on Personality in Healthy Volunteers: a Double-blind, Randomized, Placebo-controlled Study

Earlier

Oct 16, 2026TrialCardiovascular Pre-participation Evaluation With Physical Examination, Resting Electrocardiogram and Step Test in Children and Adolescents of the São Paulo Olympic Program: a Prospective Observational Study

Oct 8, 2026TrialPhysical Activity Analysis in a Cohort of Patients With Congenital Long QT Syndrome: First Steps of the Channelopathies Movement and Exercise Study (CANMOVE)

Oct 6, 2026TrialCan a Pre-workout Supplement Cause Arrhythmias During Physical Exercise in Young Physically Active Individuals? A Randomized, Double-blind, Placebo-controlled Study

Oct 6, 2026TrialEvaluation of Subcutaneous Implantable Cardioverter-defibrillator Eligibility in Patients With Arrhythmogenic Right and Left Ventricular Cardiomyopathy: a Prospective Longitudinal Pilot Cohort Study

Oct 6, 2026TrialComparison Between Isolated Foam Sclerotherapy and Foam Sclerotherapy Combined With Transdermal Laser for the Treatment of Reticular Veins and Telangiectasias: A Prospective Randomized Clinical Trial

1 more events

Oct 6, 2026TrialMolecular Autopsy in Young Individuals With Unexplained Sudden Cardiovascular Death: a Pilot Workflow at the São Paulo Death Verification Service With Cascade Genetic Screening of First-degree Relatives

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

AyahuascaPreclinical

Oncology

Acute Leukemia

CART-19Phase 2

Psychiatry

Suicide

Intravenous EsketaminePhase 3

Unknown / Other

Empathy

Intervention1: CannabidiolPhase 1

Esketamine

AyahuascaPhase 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)